Establishment of three Joubert syndrome-derived induced pluripotent stem cell (iPSC) lines harbouring compound heterozygous mutations in CC2D2A gene

被引：2

作者：

Ali, Eltahir ^{[1
]}

Ferraro, Rosalba Monica ^{[1
]}

Guglielmi, Adele ^{[1
,6
]}

Lanzi, Gaetana ^{[1
]}

Masneri, Stefania ^{[1
]}

Piovani, Giovanna ^{[2
]}

Mazzoldi, Elena Laura ^{[1
]}

Pollara, Lidia ^{[3
]}

Valente, Enza Maria ^{[3
,4
]}

Accorsi, Patrizia ^{[5
]}

Giordano, Lucio ^{[5
]}

Giliani, Silvia Clara ^{[1
]}

机构：

[1] Univ Brescia, Angelo Nocivelli Inst Mol Med, Dept Mol & Translat Med, Brescia, Italy

[2] Univ Brescia, Dept Mol & Translat Med, Biol & Genet Div, Brescia, Italy

[3] Univ Pavia, Dept Mol Med, Pavia, Italy

[4] IRCCS Mondino Fdn, Pavia, Italy

[5] ASST Spedali Civili Brescia, Unit Child Neurol & Psychiat, Brescia, Italy

[6] Univ Calif Davis, Med Ctr, Inst & Dept Pathol & Lab Med, Med Invest Neurodev Disorders MIND, Sacramento, CA 95817 USA

来源：

STEM CELL RESEARCH | 2021年 / 54卷

关键词：

Joubert syndrome; CC2D2A; iPSCs; Stemness; Pluripotency; Ciliogenesis;

D O I：

10.1016/j.scr.2021.102430

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

We have developed Joubert syndrome (JS)-derived induced pluripotent stem cell (iPSC) lines from dermal fibroblasts biopsied from a female patient harbouring novel compound heterozygous mutations in CC2D2A gene. The newly established iPSC lines provide tremendous promises for development of JS-derived neuronal cell lines to uncover the molecular and cellular mechanisms underlying the pathogenesis of JS and to develop therapeutic interventions for treatment of JS.

引用

页数：5

共 50 条

[21] Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1
Moon, Sang Yoon
Zhang, Dan
Chen, Shang-Chih
Lamey, Tina M.
Thompson, Jennifer A.
McLaren, Terri L.
De Roach, John N.
Chen, Fred K.
McLenachan, Samuel
STEM CELL RESEARCH, 2020, 54
[22] Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene
Riera, Marina
Patel, Achchhe
Corcostegui, Borja
Chang, Stanley
Corneo, Barbara
Sparrow, Janet R.
Pomares, Esther
STEM CELL RESEARCH, 2019, 35
[23] Establishment of a human induced pluripotent stem cell line, KMUGMCi003-A, from a patient with trichothiodystrophy 1 (TTD1) bearing compound heterozygous missense mutations in the ERCC2 gene
Ura, Hiroki
Togi, Sumihito
Hatanaka, Hisayo
Niida, Yo
STEM CELL RESEARCH, 2022, 64
[24] Establishment of human induced pluripotent stem cell line (SDQLCHi060-A) from a patient with AUTS2 syndrome carrying a heterozygous mutation in AUTS2 gene
Gao, Chunlai
Liu, Yi
Liu, Ning
Li, Zilong
Yang, Xiaomeng
Yang, Yanan
Xi, Yue
Tian, Jianjun
Gai, Zhongtao
STEM CELL RESEARCH, 2023, 73
[25] Generation of two familial hypercholesterolemia patient-specific induced pluripotent stem cell lines harboring heterozygous mutations in the LDLR gene
Gao, Jingshan
Li, Juana
Xu, Lingyun
Yan, Christopher D.
Knowles, Joshua W.
Wu, Joseph C.
STEM CELL RESEARCH, 2024, 78
[26] Characterization of two human induced pluripotent stem cell lines derived from Batten disease patient fibroblasts harbouring CLN5 mutations
Ofrim, Marisa
Little, Daniel
Nazari, Mina
Minnis, Christopher J.
Devine, Michael J.
Mole, Sara E.
Gissen, Paul
Lorvellec, Maelle
STEM CELL RESEARCH, 2024, 74
[27] Generation of two induced pluripotent stem cell lines (CHOCi002-A and CHOCi003-A) from Pompe disease patients with compound heterozygous mutations in the GAA gene
Christensen, Chloe
Heckman, Perla
Rha, Allisandra
Kan, Shih-Hsin
Harb, Jerry
Wang, Raymond
STEM CELL RESEARCH, 2023, 69
[28] Mutated JAK2 signal transduction in human Induced Pluripotent Stem Cell (iPSC)-derived Megakaryocytes
Pawinwongchai, Jaturawat
Jangprasert, Panchalee
Nilsri, Nungruthai
Israsena, Nipan
Rojnuckarin, Ponlapat
PLATELETS, 2022, 33 (05) : 700 - 708
[29] Establishment of induced pluripotent stem cell line CSUASOi003-A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene
Zhou, Yalan
Ding, Chengcheng
Xia, Shutao
Jing, Yutong
Mao, Shengru
Liu, Jian
Chen, Juan
Chan, Hon Fai
Tang, Shibo
Chen, Jiansu
STEM CELL RESEARCH, 2020, 44
[30] Generation of human induced pluripotent stem cell lines from five patients with Myofibrillar myopathy carrying different heterozygous mutations in the DES gene
Joanne, Pierre
Hovhannisyan, Yeranuhi
Simon, Alexandre
Revet, Gaelle
Diot, Romain
Friob, Gabriel
Calin, Denisa
Li, Zhenlin
Behin, Anthony
Wahbi, Karim
Tachdjian, Gerard
Agbulut, Onnik
STEM CELL RESEARCH, 2024, 76

← 1 2 3 4 5 →